Peter Behner - 03 Jun 2024 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Reporting relationship: Director
Issuer ticker: INKT
Reported as of: 03 Jun 2024
Net transaction value: +$15,299
SEC form: 4
Accepted by SEC: 05 Jun 2024, 14:27:56 UTC
Prior SEC filing: 05 Mar 2024
Next SEC filing: 05 Sep 2024
Source filing: View source filing
Reporting owner signature: By: /s/ Christine Klaskin, Attorney-in-Fact

Key filing fact

Peter Behner filed Form 4 for MiNK Therapeutics, Inc. (INKT) on 05 Jun 2024.

Key facts

This page summarizes Peter Behner's Form 4 filing for MiNK Therapeutics, Inc. (INKT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2024, 14:27.

Change

Previous filing in this sequence was filed on 05 Mar 2024.
Current net transaction value: +$15,299.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INKT transaction

Common Stock

Award

Transaction value: $15,299
Shares: +15,454
Change %: +21%
Price: $0.9900
Shares after: 90,481
Date: 03 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.